These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10583373)

  • 1. Binding to human dipeptidyl peptidase IV by adenosine deaminase and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted beta propeller domain.
    Abbott CA; McCaughan GW; Levy MT; Church WB; Gorrell MD
    Eur J Biochem; 1999 Dec; 266(3):798-810. PubMed ID: 10583373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding.
    Aertgeerts K; Ye S; Shi L; Prasad SG; Witmer D; Chi E; Sang BC; Wijnands RA; Webb DR; Swanson RV
    Protein Sci; 2004 Jan; 13(1):145-54. PubMed ID: 14691230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relating structure to function in the beta-propeller domain of dipeptidyl peptidase IV. Point mutations that influence adenosine deaminase binding, antibody binding and enzyme activity.
    Gorrell MD; Abbott CA; Kähne T; Levy MT; Church WB; McCaughan GW
    Adv Exp Med Biol; 2000; 477():89-95. PubMed ID: 10849733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of cysteines in rat dipeptidyl peptidase IV/CD26 in processing and proteolytic activity.
    Dobers J; Grams S; Reutter W; Fan H
    Eur J Biochem; 2000 Aug; 267(16):5093-100. PubMed ID: 10931192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of CD26/dipeptidyl-peptidase IV in complex with adenosine deaminase reveals a highly amphiphilic interface.
    Weihofen WA; Liu J; Reutter W; Saenger W; Fan H
    J Biol Chem; 2004 Oct; 279(41):43330-5. PubMed ID: 15213224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The binding site of human adenosine deaminase for CD26/Dipeptidyl peptidase IV: the Arg142Gln mutation impairs binding to cd26 but does not cause immune deficiency.
    Richard E; Arredondo-Vega FX; Santisteban I; Kelly SJ; Patel DD; Hershfield MS
    J Exp Med; 2000 Nov; 192(9):1223-36. PubMed ID: 11067872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of deoxycoformycin and Val-boroPro on the associated catalytic activities of lymphocyte CD26 and ecto-adenosine deaminase.
    Jeanfavre DD; Woska JR; Pargellis CA; Kennedy CA; Prendergast J; Stearns C; Reilly PL; Barton RW; Bormann BJ
    Biochem Pharmacol; 1996 Dec; 52(11):1757-65. PubMed ID: 8986139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of adenosine deaminase binding domain on CD26 and its immunoregulatory effect on T cell activation.
    Dong RP; Tachibana K; Hegen M; Munakata Y; Cho D; Schlossman SF; Morimoto C
    J Immunol; 1997 Dec; 159(12):6070-6. PubMed ID: 9550406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clustered charged amino acids of human adenosine deaminase comprise a functional epitope for binding the adenosine deaminase complexing protein CD26/dipeptidyl peptidase IV.
    Richard E; Alam SM; Arredondo-Vega FX; Patel DD; Hershfield MS
    J Biol Chem; 2002 May; 277(22):19720-6. PubMed ID: 11901152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D structure of the CD26-ADA complex obtained by cryo-EM and single particle analysis.
    Ludwig K; Fan H; Dobers J; Berger M; Reutter W; Böttcher C
    Biochem Biophys Res Commun; 2004 Jan; 313(2):223-9. PubMed ID: 14684150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of dipeptidyl peptidase IV on enzymatic properties of adenosine deaminase.
    Sharoyan S; Antonyan A; Mardanyan S; Lupidi G; Cristalli G
    Acta Biochim Pol; 2006; 53(3):539-46. PubMed ID: 16929383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structures of HIV-1 Tat-derived nonapeptides Tat-(1-9) and Trp2-Tat-(1-9) bound to the active site of dipeptidyl-peptidase IV (CD26).
    Weihofen WA; Liu J; Reutter W; Saenger W; Fan H
    J Biol Chem; 2005 Apr; 280(15):14911-7. PubMed ID: 15695814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel form of dipeptidylpeptidase IV found in human serum. Isolation, characterization, and comparison with T lymphocyte membrane dipeptidylpeptidase IV (CD26).
    Duke-Cohan JS; Morimoto C; Rocker JA; Schlossman SF
    J Biol Chem; 1995 Jun; 270(23):14107-14. PubMed ID: 7539799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides.
    Durinx C; Lambeir AM; Bosmans E; Falmagne JB; Berghmans R; Haemers A; Scharpé S; De Meester I
    Eur J Biochem; 2000 Sep; 267(17):5608-13. PubMed ID: 10951221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanism and structural basis of interactions of dipeptidyl peptidase IV with adenosine deaminase and human immunodeficiency virus type-1 transcription transactivator.
    Fan H; Tansi FL; Weihofen WA; Böttcher C; Hu J; Martinez J; Saenger W; Reutter W
    Eur J Cell Biol; 2012 Apr; 91(4):265-73. PubMed ID: 21856036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct association of adenosine deaminase with a T cell activation antigen, CD26.
    Kameoka J; Tanaka T; Nojima Y; Schlossman SF; Morimoto C
    Science; 1993 Jul; 261(5120):466-9. PubMed ID: 8101391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structure and function of human dipeptidyl peptidase IV, possessing a unique eight-bladed beta-propeller fold.
    Hiramatsu H; Kyono K; Higashiyama Y; Fukushima C; Shima H; Sugiyama S; Inaka K; Yamamoto A; Shimizu R
    Biochem Biophys Res Commun; 2003 Mar; 302(4):849-54. PubMed ID: 12646248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citrullination of adenosine deaminase impairs its binding to dipeptidyl peptidase IV.
    Karapetyan L; Sharoyan S; Mardanyan S; Lupidi G; Cuccioloni M; Angeletti M; Markarian S; Shilajyan H; Antonyan A
    Biophys Chem; 2022 Jul; 286():106820. PubMed ID: 35468399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine down-regulates the surface expression of dipeptidyl peptidase IV on HT-29 human colorectal carcinoma cells: implications for cancer cell behavior.
    Tan EY; Mujoomdar M; Blay J
    Am J Pathol; 2004 Jul; 165(1):319-30. PubMed ID: 15215186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipeptidyl-peptidase IV-beta, a novel form of cell-surface-expressed protein with dipeptidyl-peptidase IV activity.
    Jacotot E; Callebaut C; Blanco J; Krust B; Neubert K; Barth A; Hovanessian AG
    Eur J Biochem; 1996 Jul; 239(2):248-58. PubMed ID: 8706727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.